Hercules Capital, Inc.

  • Market Cap: Small Cap
  • Industry: Capital Markets
  • ISIN: US4270965084
USD
18.94
0.18 (0.96%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Hercules Capital, Inc. stock-summary
stock-summary
Hercules Capital, Inc.
Capital Markets
Hercules Capital, Inc. is a specialty finance company. The Company is an internally managed, non-diversified, closed-end investment company. The Company focuses on providing senior secured venture growth loans to venture capital-backed companies in a range of technology, life sciences, and sustainable and renewable technology industries. The Company's investment objective is to maximize its portfolio total return by generating current income from its debt investments and capital appreciation from its warrant and equity-related investments. The Company's primary business objectives are to increase its net income, net operating income and net asset value (NAV) by investing in structured debt with warrants and equity of venture capital-backed companies in technology-related industries with attractive current yields and the potential for equity appreciation and realized gains. The Company focuses its investments in companies active in the technology industry sub-sectors.
Company Coordinates stock-summary
Company Details
400 Hamilton Ave Ste 310 , PALO ALTO CA : 94301-1805
stock-summary
Tel: 1 650 2893060
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 20 Schemes (2.95%)

Foreign Institutions

Held by 53 Foreign Institutions (3.5%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Robert Badavas
Independent Chairman of the Board
Ms. Gayle Crowell
Independent Director
Mr. Thomas Fallon
Independent Director
Ms. Carol Foster
Independent Director
Mr. Joseph Hoffman
Independent Director
Mr. Brad Koenig
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
80 Million
(Quarterly Results - Jun 2025)
Net Profit:
78 Million
stock-summary
Industry

Capital Markets

stock-summary
Market cap

USD 3,534 Million (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

8.13%

stock-summary
Debt Equity

-999,999.00

stock-summary
Return on Equity

11.94%

stock-summary
Price to Book

1.64